Erzhu Jiedu decoction ameliorates liver precancerous lesions in a rat model of liver cancer

Precancerous lesions are the intermediate stage in the development of liver cancer from cirrhosis. Early intervention measures can effectively prevent the occurrence of liver cancer and prolong the lives of patients, resulting in greater economic effects. Erzhu Jiedu decoction (EJD) is a semiempirical formula that is used in the treatment of cirrhosis and liver cancer according to the academic philosophy of “Preventive treatment of disease” and has achieved good curative effects in clinical practice. The purpose of this study was to investigate the effect of EJD on liver precancerous lesions induced by diethylnitrosamine (DEN) in rats. The results showed that EJD improved the general conditions (body weight, ALT, AST, and GGT) and reduced the number of precancerous lesions in the rat model. Notably, the medium dose of EJD (1.05 g/kg) had better treatment effects than the low dose of EJD, and the high dose of EJD did not further improve the liver lesions compared to the medium dose of EJD. Moreover, EJD effectively reduced the DEN-induced GST-Pi, AFP, CK19, c-Myc, and Ki67 protein expression in liver precancerous tissues. Interestingly, EJD significantly reduced YAP and TAZ mRNA expression in the liver precancerous lesions. Collectively, EJD protects against in the initiation of liver cancer and the regulation of c-Myc and Hippo signaling pathways may be the underlying mechanism.

[1]  Kaixian Chen,et al.  A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D. Don. , 2020, Journal of ethnopharmacology.

[2]  An-jun Liu,et al.  An alcohol-soluble polysaccharide from Atractylodes macrocephala Koidz induces apoptosis of Eca-109 cells. , 2019, Carbohydrate polymers.

[3]  Hongliu Sun,et al.  Huganpian, a traditional chinese medicine, inhibits liver cancer growth in vitro and in vivo by inducing autophagy and cell cycle arrest. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Juan Yu,et al.  Polysaccharide extracted from Atractylodes macrocephala Koidz (PAMK) induce apoptosis in transplanted H22 cells in mice. , 2019, International journal of biological macromolecules.

[5]  Ting Duan,et al.  Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Yongye Huang,et al.  Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science , 2019, Cancer medicine.

[7]  Hui Zhang,et al.  Preventive and therapeutic role of Tanshinone ⅡA in hepatology. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  D. Largaespada,et al.  Sodium tanshinone IIA sulfonate ameliorates hepatic steatosis by inhibiting lipogenesis and inflammation. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  Gisela Schwab,et al.  Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma , 2018, The New England journal of medicine.

[10]  M. Kudo,et al.  Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial , 2018, The Lancet.

[11]  Sha Xiong,et al.  Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  S. Shuto,et al.  A covalent G-site inhibitor for glutathione S-transferase Pi (GSTP1-1). , 2017, Chemical communications.

[13]  Jun Li,et al.  Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. , 2017, Gastroenterology.

[14]  S. Friedman,et al.  Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. , 2017, Gastroenterology.

[15]  F. Camargo,et al.  Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis. , 2017, Gastroenterology.

[16]  B. Chauffert,et al.  Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[17]  Yang Cheng,et al.  Antiviral activities of atractylon from Atractylodis Rhizoma , 2016, Molecular medicine reports.

[18]  Pei Wang,et al.  Effects on the tumor specific growth factor and tumor necrosis factor α in rats’ precancerous lesion of primary hepatocellular carcinoma by direct moxibustion at Ganshu (BL 18) acupoint , 2016, Chinese Journal of Integrative Medicine.

[19]  Menghua Liu,et al.  The Hedyotis diffusa Willd. (Rubiaceae): A Review on Phytochemistry, Pharmacology, Quality Control and Pharmacokinetics , 2016, Molecules.

[20]  Tao Zeng,et al.  Interferon–microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis , 2016, Gut.

[21]  Shan Wang,et al.  The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[22]  K. Ko,et al.  Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases , 2015, Mediators of inflammation.

[23]  Ying-yi Zhang,et al.  Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[24]  Hossam Haick,et al.  Detection of precancerous gastric lesions and gastric cancer through exhaled breath , 2015, Gut.

[25]  L. Teng,et al.  YAP/TAZ for cancer therapy: opportunities and challenges (review). , 2015, International journal of oncology.

[26]  K. Pearson,et al.  Resveratrol and cancer: focus on in vivo evidence , 2014, Endocrine-related cancer.

[27]  Yuzhong Zhang,et al.  Protection of a new heptapeptide from Carapax trionycis against carbon tetrachloride-induced acute liver injury in mice. , 2013, Chemical & pharmaceutical bulletin.

[28]  F. Sandouk,et al.  Precancerous Lesions in Colorectal Cancer , 2013, Gastroenterology research and practice.

[29]  Y. Niu,et al.  Chemical and preclinical studies on Hedyotis diffusa with anticancer potential , 2013, Journal of Asian natural products research.

[30]  M. R. Bailey,et al.  Ginkgo biloba: indications, mechanisms, and safety. , 2013, The Psychiatric clinics of North America.

[31]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[32]  Y. N. Park.  Update on precursor and early lesions of hepatocellular carcinomas. , 2011, Archives of pathology & laboratory medicine.

[33]  Bao-feng Wang,et al.  In Vitro and In Vivo Antitumor Activity of Scutellaria barbate Extract on Murine Liver Cancer , 2011, Molecules.

[34]  M. Colombo,et al.  Liver precancerous lesions and hepatocellular carcinoma: the histology report. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[35]  Min-Ho Kim,et al.  Atractylenolide III, a sesquiterpenoid, induces apoptosis in human lung carcinoma A549 cells via mitochondria-mediated death pathway. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  Z. Dai,et al.  Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3. , 2008, World journal of gastroenterology.

[37]  Yoshiyuki Suzuki,et al.  Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis , 2006, Cancer.

[38]  H. Devaraj,et al.  Induction and expression of GST-Pi foci in the liver of Cyclophosphamide-administered rats. , 2006, Toxicology.